We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$497M
AUM Growth
+$28.7M
Cap. Flow
-$22.5M
Cap. Flow %
-4.53%
Top 10 Hldgs %
100%
Holding
7
New
Increased
2
Reduced
2
Closed

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$6.49M
2
LCTX icon
Lineage Cell Therapeutics
LCTX
+$1.12M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$29.6M
2
MNST icon
Monster Beverage
MNST
+$589K

Sector Composition

Rank Sector Weight
1 Miscellaneous 44.66%
2 Healthcare 33.55%
3 Consumer Staples 21.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOR
1
DELISTED
QUESTCOR PHARMA INC
QCOR
$152M 30.62%
2,796,660
-500,000
-15% -$29.6M
STAA icon
2
STAAR Surgical
STAA
$1.13B
$112M 22.42%
6,887,095
+485,456
+8% +$6.49M
MNST icon
3
Monster Beverage
MNST
$87.7B
$108M 21.79%
19,189,632
-120,000
-0.6% -$589K
MNST icon
4
PUT
Monster Beverage
MNST
$87.7B
$67.8M 13.63%
12,000,000
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$263M
$33.6M 6.75%
11,550,394
+371,755
+3% +$1.12M
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
$21.8M 4.38%
817,029
SLTM
7
DELISTED
SOLTA MED INC (DE)
SLTM
$2.01M 0.4%
680,723

Similar funds

Broadwood Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Broadwood Capital held 7 positions worth $497M, up 6.1% from $469M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $22.5M in Q4 2013, reducing 2 holdings. Its largest reduction was QUESTCOR PHARMA INC, cutting an estimated $29.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, down from 52% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Broadwood Capital added an estimated $6.49M to STAAR Surgical.

  • Broadwood Capital added most to STAAR Surgical in Q4 2013, an estimated $6.49M increase.
  • Broadwood Capital's biggest Q4 2013 reduction was QUESTCOR PHARMA INC, cutting an estimated $29.6M.
  • Broadwood Capital's ten largest holdings make up 100% of its $497M portfolio in Q4 2013.
  • Broadwood Capital opened 0 new positions and closed 0 in Q4 2013.
  • Broadwood Capital's portfolio value rose 6.1% quarter-over-quarter to $497M.

Based on Broadwood Capital's 13F filing for Q4 2013, filed 14 Feb 2014.